Treatment and prevention of spontaneous intracerebral hemorrhage: Comparison of EUSI and AHA/ASA recommendations

Expert Review of Neurotherapeutics

Volumn 7, Issue 10, 2007, Pages 1401-1416

  Jüttler, Eric ^a   Steiner, Thorsten ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Clinical trials; Intracerebral hemorrhage; Management; Recommendations

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; APROTININ; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; PROTAMINE SULFATE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID; UROKINASE;

BRAIN HEMATOMA; BRAIN HEMORRHAGE; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE ESCALATION; EPILEPSY; EVIDENCE BASED MEDICINE; HEALTH CARE ORGANIZATION; HUMAN; HYDROCEPHALUS; INTRACRANIAL PRESSURE; MORBIDITY; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; RISK FACTOR; THROMBOEMBOLISM;

AMERICAN HEART ASSOCIATION; CEREBRAL HEMORRHAGE; CLINICAL TRIALS AS TOPIC; EUROPE; HEALTH PLANNING GUIDELINES; HUMANS; TREATMENT OUTCOME;

EID: 35548929905     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.7.10.1401     Document Type: Review

References (103)

1. Ayala C, Croft JB, Greenlund KJ et al. Sex differences in US mortality rates for stroke and stroke subtypes by race/ethnicity and age, 1995-1998. Stroke 33(5), 1197-1201 (2002).
2. Weimar C, Weber C, Wagner M et al. Management patterns and health care use after intracerebral hemorrhage. A cost-of-illness study from a societal perspective in Germany. Cerebrovasc. Dis. 15, 29-36 (2003).
3. Labovitz DL, Halim A, Boden-Albala B et al. The incidence of deep and lobar intracerebral hemorrhage in whites, blacks, and Hispanics. Neurology 65(4), 518-522 (2005).
4. Jiang B, Wang WZ, Chen H et al. Incidence and trend of stroke and its subtypes in China: results from three large cities. Stroke 37(1), 63-68 (2006).
5. Qureshi AI, Tuhrim S, Broderick JP et al. Spontaneous intracerebral hemorrhage. N. Engl. J. Med. 344(19), 1450-1460 (2001).
6. Sudlow CL, Warlow CP. Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration. Stroke 28(3), 491-499 (1997).
7. O'Donell HC, Rosand J, Knudsen KA et al. Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N. Engl. J. Med. 342(4), 240-245 (2000).
8. Ariesen MJ, Claus SP, Rinkel GJ et al. Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke 34(8), 2060-2065 (2003). • Very integrated review of risk factors for intracerebral hemorrhage (ICH).
9. Counsell C, Boonyakarnkul S, Dennis M et al. Primary intracerebral hemorrhage in the Oxfordshire community stroke project. 2. Prognosis. Cerebrovasc. Dis. 5(1), 26-34 (1995).
10. Flaherty ML, Haverbusch M, Sekar P et al. Long-term mortality after intracerebral hemorrhage. Neurology 66(8), 1182-1186 (2006).
11. Dennis MS. Outcome after brain hemorrhage. Cerebrovasc. Dis. 16(Suppl. 1), 9-13 (2003).
12. Ruiz-Sandoval JL, Chiquete E, Romero-Vargas S et al. Grading scale for prediction of outcome in primary intracerebral hemorrhages. Stroke 38(5), 1641-1644 (2007).
13. Tuhrim S, Dambrosia JM, Price TR et al. Intracerebral hemorrhage: external validation and extension of a model for prediction of 30-day survival. Ann. Neurol. 29(6), 658-663 (1991).
14. Hemphill JC 3rd, Bonovich DC, Besmertis L et al. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 32(4), 891-897 (2001).
15. Cheung RT, Zou LY. Use of the original, modified, or new intracerebral hemorrhage score to predict mortality and morbidity after intracerebral hemorrhage. Stroke 34(7), 1717-1722 (2003).
16. Steiner T, Kaste M, Forsting M et al. Recommendations for the management of intracerebral hemorrhage - part I: spontaneous intracerebral hemorrhage. Cerebrovasc. Dis. 22(4), 294-316 (2006). •• Most comprehensive recommendations for the management of spontaneous ICH from the European Stroke Initiative.
17. Broderick J, Connolly S, Feldmann E et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults. 2007 update. Stroke 38(6), 2001-2023 (2007). •• Most comprehensive recommendations for the management of spontaneous ICH from the American Heart Association/American Stroke Association.
18. NINDS ICH Workshop participants. Priorities for clinical research in intracerebral hemorrhage. Report from a National Institute of Neurologic Disorders and Stroke Workshop. Stroke 36(3), e23-e41 (2005). •• Expert report framing the topics of clinical research in ICH for the next decade.
19. Gebel JM Jr, Jauch EC, Brott TG et al. Natural history of perihematomal edema in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke 33(11), 2631-2635 (2002).
20. Castillo J, Davalos A, Alvarez-Sabin J et al. Molecular signatures of brain injury after intracerebral hemorrhage. Neurology 58(4), 624-629 (2002).
21. Zhao X, Sun G, Zhang J et al. Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages. Ann. Neurol. 61(4), 352-362 (2007).
22. Brainin M, Barnes M, Baron JC et al. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces - revised recommendations 2004. Eur. J. Neurol. 11(9), 577-581 (2004).
23. Ogilvy CS, Stieg PE, Awad I et al. Recommendations for the management of intracranial arteriovenous malformations. Stroke 32(6), 1458-1471 (2001).
24. Goldstein LB, Simel DL. Is the patient having a stroke? JAMA 293(19), 2391-2402 (2005).
25. Weir CJ, Murray GD, Adams FG et al. Poor accuracy of stroke scoring systems for differential clinical diagnosis of intracranial haemorrhage and infarction. Lancet 344(8928), 999-1002 (1994).
26. Juttler E, Fiebach J, Schellinger PD. Diagnostic imaging for acute ischemic stroke management. Expert Rev. Med. Devices 3(1), 113-126 (2006).
27. Fiebach JB, Schellinger PD, Gass A et al. Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage. A multicenter study on the validity of stroke imaging. Stroke 35(2), 502-507 (2004). • Clinical neuroimaging study demonstrating the equality of stroke MRI and CT scanning in detecting or excluding hyperacute intracerebral hemorrhage.
28. Kidwell CS, Chelala JA, Saver JL et al. Comparison of MRI and CT detection of acute intracerebral hemorrhage. JAMA 292(15), 1823-1830 (2004).
29. Passero S, Ciacci G, Ulivelli M. The influence of diabetes and hyperglycemia on clinical course after intracerebral hemorrhage. Neurology 61(10), 1351-1356 (2003).
30. Leira R, Davalos A, Silva Y, Gil-Peralta A et al. Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors. Neurology 63(3), 461-467 (2004).
31. Schwarz S, Hafner K, Aschoff A et al. Incidence and prognostic significance of fever following intracerebral hemorrhage. Neurology 54(2), 354-361 (2000).
32. Fujii Y, Takeuchi S, Sasaki O et al. Multivariate analysis of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke 29(6), 1160-1166 (1998).
33. Qureshi AI, Bliwise DL, Bliwise NG et al. Rate of 24-hour blood pressure decline and mortality after spontaneous intracerebral hemorrhage: a retrospective analysis with a random effects regression model. Crit. Care Med. 27(3), 480-485 (1999).
34. Dandapani BK, Suzuki S, Kelley RE et al. Relation between blood pressure and outcome in intracerebral hemorrhage. Stroke 26(1), 21-24 (1995).
35. Broderick JP, Diringer MN, Hill MD et al. Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke 38(3), 1072-1075 (2007).
36. Willmot M, Leonardi-Bee J, Bath PM. High blood pressure in acute stroke and subsequent outcome. A systematic review. Hypertension 43(1), 18-24 (2004).
37. Brott T, Broderick J, Kothari R et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 28(1), 1-5 (1997). • First prospective study providing evidence for the time course of early hemorrhage growth.
38. Kazui S, Naritomi H, Yamamoto H et al. Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke 27(10), 1783-1787 (1996).
39. Zhao X, Wang Y, Wang C et al. Quantitative evaluation for secondary injury to perihematoma of hypertensive cerebral hemorrhage by functional MR and correlation analysis with ischemic factors. Neurol. Res. 28(1), 66-70 (2006).
40. Siddique MS, Fernandes HM, Wooldridge TD et al. Reversible ischemia around intracerebral hemorrhage: a single-photon emission computerized tomography study. J. Neurosurg. 96(4), 736-741 (2002).
41. Rosand J, Eskey C, Yuchiao C et al. Dynamic single-section CT demonstrates reduced cerebral blood flow in acute intracerebral hemorrhage. Cerebrovasc. Dis. 14(3-4), 214-220 (2002).
42. Herweh C, Juttler E, Schellinger PD et al. Evidence against a perihemorrhagic penumbra provided by perfusion CT. Stroke (2007) (In Press).
43. Fainardi E, Borrelli M, Saletti A et al. Assessment of acute spontaneous intracerebral hematoma by CT perfusion imaging. J. Neuroradiol. 32(5), 333-336 (2005).
44. Butcher KS, Baird T, MacGregor L et al. Perihematomal edema in primary intracerebral hemorrhage is plasma derived. Stroke 35(8), 1879-1885 (2004).
45. Schellinger PD, Fiebach JB, Hoffmann K et al. Stroke MRI in intracerebral hemorrhage: is there a perihemorrhagic penumbra? Stroke 34(7), 1674-1679 (2003).
46. Kidwell CS, Saver JL, Mattiello J et al. Diffusion-perfusion MR evaluation of perihematomal injury in hyperacute intracerebral hemorrhage. Neurology 57(11), 1611-1617 (2001).
47. Zazulia AR, Diringer MN, Videen TO et al. Hypoperfusion without ischemia surrounding intracerebral hemorrhage. J. Cereb. Blood Flow Metab. 21(7), 804-810 (2001).
48. Jauch EC, Lindsell CJ, Adeoye O et al. Lack of evidence for an association between hemodynamic variables and hematoma growth in spontaneous intracerebral hemorrhage. Stroke 37(8), 2061-2065 (2006).
49. Qureshi AI, Mohammad YM, Yahia AM et al. A prospective multicenter study to evacuate the feasibility and safety of aggressive antihypertensive treatment in patients with acute intracerebral hemorrhage. J. Intensive Care Med. 20(1), 34-42 (2005).
50. Ohwaki K, Yano E, Nagashima H et al. Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke 35(6), 1364-1367 (2004).
51. Powers WJ, Zazulia AR, Videen TO et al. Autoregulation of cerebral blood flow surrounding acute (6-22 h) intracerebral hemorrhage. Neurology 57(1), 18-24 (2001).
52. Becker KJ, Baxter AB, Bybee HM et al. Extravasation of radiographic contrast is an independent predictor of death in primary intracerebral hemorrhage. Stroke 30(10), 2025-2032 (1999).
53. Diringer MN, Edwards DF. Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit. Care Med. 29(3), 635-640 (2001).
54. Adams HP Jr, del Zoppo G, Alberts MJ et al. Guidelines for the early management of adults with ischemic stroke. Stroke 38(5), 1655-1711 (2007). •• Currently the most topical guidelines for the treatment of ischemic stroke from the American Heart Association/American Stroke Association.
55. Hacke W, Kaste M, Bogousslavsky J et al. European Stroke Initiative recommendations for stroke management - update 2003. Cerebrovasc. Dis. 16(4), 311-337 (2003). • Latest guidelines for ischemic stroke management from the European Stroke Initiative.
56. Broderick J, Brott T, Duldner JE et al. Volume of intracerebral hemorrhage: a powerful and easy-to-use predictor of 30-day mortality. Stroke 24(7), 987-993 (1993). • Study that actually brought the concept of volume predicts outcome into clinical practice.
57. Diringer MN, Edwards DF, Zazulia AR. Hydrocephalus: a previously unrecognized predictor of poor outcome from supratentorial intracerebral hemorrhage. Stroke 29(7), 1352-1357 (1998).
58. Fujii Y, Tanaka R, Takeuchi S, Koike T, Minakawa T, Sasaki O. Hematoma enlargement in spontaneous intracerebral hemorrhage. J. Neurosurg. 80(1), 51-57 (1994).
59. Gregson BA, Mendelow AD. Surgical trial in lobar intracerebral hemorrhage (STICH II). Proceedings of the Scottish and Newcastle Neurosurgical Research Network 7-10 (2005).
60. Auer LM, Deinsberger W, Niederkorn K et al. Endoscopic surgery versus medical treatment for spontaneous intracerebral hematoma: a randomized study. J. Neurosurg. 70(4), 530-535 (1989).
61. Mendelow AD, Gregson BA, Fernandes HM et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral hematomas in the International Surgical Trial in Intracerebral Hemorrhage (STICH): a randomized trial. Lancet 365(9457), 387-397 (2005). •• Largest trial investigating surgical treatment of ICH.
62. Mayer SA, Brun N, Broderick J et al. Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage. Stroke 36(1), 74-79 (2005). • Trial investigating the effect of hemostatic therapy by recombinant factor VIIa for the treatment of acute ICH.
63. Mayer SA, Brun NC, Begtrup K et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N. Engl. J. Med. 352(8), 777-785 (2005). • Trial investigating the effect of hemostatic therapy by recombinant factor VIIa for the treatment of acute ICH.
64. Steiner T, Diringer MN, Schneider D et al. Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII. Neurosurgery 59(4), 767-774 (2006). • Trial investigating the effect of hemostatic therapy by recombinant factor VIIa for the treatment of acute ICH.
65. Mayer SA, Brun NC, Begtrup K et al. Randomized, placebo-controlled, double-blind Phase III study to assess rFVIIa efficacy in acute intracerebral hemorrhage: the FAST trial. Cerebrovasc. Dis. 23(Suppl. 2), 10 (2007) (Abstract 1). • Trial investigating the effect of hemostatic therapy by recombinant factor VIIa for the treatment of acute ICH.
66. Tuhrim S, Horowitz DR, Sacher M et al. Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhage. Crit. Care Med. 27(3), 617-621 (1999).
67. Naff NJ, Carhuapoma JR, Williams MA et al. Treatment of intravcentricular hemorrhage with urokinase: effects on 30-day survival. Stroke 31(4), 841-847 (2000).
68. Naff NJ, Hanley DF, Keyl PM et al. Intraventricular thrombolysis speeds blood clot resolution: results of a pilot, prospective, randomized double-blind, controlled trial. Neurosurgery 54(3), 577-584 (2004).
69. Hanley D. Results of clear IVH B: dose-response for 3rd and 4th ventricular blood clearance. Cerebrovasc. Dis. 23(Suppl. 2), 54 (2007) (Abstract 3).
70. Go AS, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285(18), 2370-2375 (2001).
71. Steiner T, Diringer M, Rosand J. Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and open questions. Stroke 37(1), 256-262 (2006). • Integrated review of the treatment of oral anticoagulation treatment-related ICH.
72. Fang MC, Chang Y, Hylek EM et al. Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann. Intern. Med. 141(10), 745-752 (2004).
73. Flibotte JJ, Hagan N, O'Donnell J et al. Warfarin, hematoma expansion and outcome of intracerebral hemorrhage. Neurology 63(6), 1059-1064 (2004).
74. Rosand J, Eckman MH, Knudsen KA et al. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch. Intern. Med. 164(8), 880-884 (2004).
75. Ananthasubramaniam K, Beattie JN, Rosman HS et al. How safely and for how long can warfarin therapy be withheld in prothetic heart valve patients hospitalized with a major hemorrhage? Chest 119(2), 478-484 (2001).
76. Phan TG, Koh M, Wijdicks EF. Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk. Arch. Neurol. 57(12), 1710-1713 (2000).
77. Bertram M, Bonsanto M, Hacke W et al. Managing the therapeutic dilemma: patients with spontaneous intracerebral hemorrhage and urgent need for anticoagulation. J. Neurol. 247(3), 209-214 (2000).
78. Huttner HB, Schellinger PD, Hartmann M et al. Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy. Stroke 37(6), 1465-1470 (2006).
79. Eckman MH, Rosand J, Knudsen KA et al. Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke 34(7), 1710-1716 (2003).
80. Gregory PC, Kuhlemeier KV. Prevalence of venous thromboembolism in acute hemorrhagic and thromboembolic stroke. Am. J. Phys. Med. Rehabil. 82(5), 364-369 (2003).
81. Vespa PM, O'Phelan K, Shah M et al. Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome. Neurology 60(9), 1441-1446 (2003).
82. Berger AR, Lipton RB, Lesser ML, Lantos G, Portenoy RK. Early seizures following intracerebral hemorrhage: implications for therapy. Neurology 38(9), 1363-1365 (1988).
83. Lacut K, Bressollette L, Le Gal G et al. Prevention of venous thrombosis in patients with acute intracerebral hemorrhage. Neurology 65(6), 865-869 (2005).
84. Davis SM, Donnan GA. Effective prophylaxis for deep venous thrombosis after stroke: both low-dose anticoagulation and stockings for most cases. Stroke 35(12), 2910 (2004).
85. Adams HP Jr. Effective prophylaxis for deep vein thrombosis after stroke: low-dose anticoagulation rather than stockings alone: for. Stroke 35(12), 2911-2912 (2004).
86. Dennis MS. Effective prophylaxis for deep vein thrombosis after stroke: low-dose anticoagulation rather than stockings alone: against. Stroke 35(12), 2912-2913 (2004).
87. Toni D, Chamorro A, Kaste M et al. Acute treatment of ischaemic stroke. European Stroke Initiative. Cerebrovasc. Dis. 17(Suppl. 2), 30-46 (2004).
88. Passero S, Rocchi R, Rossi S et al. Seizures after spontaneous supratentorial inracerebral hemorrhage. Epilepsia 43(10), 1175-1180 (2002).
89. Huttner HB, Nagel S, Tognoni G et al. Intracerebral hemorrhage with severe ventricular involvement: lumbar drainage for communicating hydrocephalus. Stroke 38(1), 183-187 (2007).
90. Becker KJ, Baxter AB, Cohen WA et al. Withdrawal of support in intracerebral hemorrhage may lead to self-fulfilling prophecies. Neurology 56(6), 766-772 (2001).
91. Bae H, Jeong D, Doh J et al. Recurrence of bleeding in patients with hypertensive intracerebral hemorrhage. Cerebrovasc. Dis. 9(2), 102-108 (1999).
92. Chen CH, Huang CW, Chen HH et al. Recurrent hypertensive intracerebral hemorrhage among Taiwanese. Kaohsiung J. Med. Sci. 17(11), 556-563 (2001).
93. Woo D, Haverbusch M, Sekar P et al. Effect of untreated hypertension on hemorrhagic stroke. Stroke 35(7), 1703-1708 (2004).
94. PROGRESS Collaborative Group. Randomized trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischemic attack. Lancet 358(9287), 1033-1041 (2001).
95. The SPARCL Investigators. The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) study. Cerebrovasc. Dis. 21(Suppl. 4), 1 (2006).
96. Diener HC, Bogousslavsky J, Brass LM et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischemic stroke or transient ischemic attack in high-risk patients (MATCH): randomized, double-blind, placebo-controlled trial. Lancet 364(9413), 331-337 (2004).
97. He J, Whelton PK, Vu B, Klag MJ. Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA 280(22), 1930-1935 (1998).
98. Teernstra OP, Evers SM, Lodder J et al. Stereotactic treatment of intracerebral hematoma by means of a plasminogen activator: a multicenter randomized controlled trial (SICHPA). Stroke 34(4), 968-974 (2003).
99. Zuccarello M, Brott T, Derex L et al. Early surgical treatment for supratentorial intracerebral hemorrhage. A randomized feasibility study. Stroke 30(9), 1833-1839 (1999).
100. Stapf C, van der Worp HB, Steiner T et al. Stroke research priorities for the next decade-a supplement statement on intracranial haemorrhage Cerebrovasc. Dis. 23(4), 318-319 (2007). • Expert statement of current clinical research priorities in ICH.
101. Stroke trials registry www.strokecenter.org/trials
102. EUSI www.eusi-stroke.org
103. Mendelow AD. More conclusions from the International Surgical Trial in Intracerebral Hemorrhage (STICH) http://stroke-university.com/view